FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES

Clinical trials for FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES trials appear

Sign up with your email to follow new studies for FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Early trial tests common cancer drug for rare bleeding disorder

Disease control Recruiting now

This early-stage study is testing whether a drug called imatinib, already used for some cancers, can help people with a specific inherited gene change (RUNX1 mutation). People with this mutation often bruise or bleed easily and have a higher lifetime risk of blood cancers. The ma…

Matched conditions: FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES

Get alerted when new FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO MYELOID MALIGNANCIES trials appear

Early trial tests common cancer drug for rare bleeding disorder